3SBio Priced At $331M In Go-Private Buyout Offer

Law360, New York (September 12, 2012, 5:26 PM EDT) -- Chinese biotech firm 3SBio Inc. is contemplating a buyout bid from a consortium led by its CEO that includes a China-focused private equity investor, it said Wednesday, in deal that would value the company at $331 million and take it private.

Among the potential buyers is a unit of CITIC Private Equity Funds Management Co. Ltd., along with 3SBio Chairman and CEO Jing Lou. Under the nonbinding proposal's terms, existing 3SBio investors would receive $15 per American Depositary Share, representing a roughly 30 percent premium over...
To view the full article, register now.